Reckitt Benckiser to pay $1.4bn over opioid treatment sales

12-07-2019

Sarah Morgan

Reckitt Benckiser to pay $1.4bn over opioid treatment sales

Casimiro PT / Shutterstock.com

Reckitt Benckiser has agreed to pay a $1.4 billion fine to settle a US investigation into the sales and marketing of opioid addiction treatment Suboxone film (buprenorphine and naloxone) by its former prescriptions business.


Reckitt Benckiser, FTC, antitrust, generics, competition, opioid crisis, settlements, DoJ, prescriptions, Suboxone, opioid addiction

LSIPR